What is DCTH? Delcath Systems, Inc. Delcath Systems, Inc. (NASDAQ: DCTH) is a publicly traded specialty pharmaceutical and medical device company[1] that develops percutaneous perfusion technologies for the targeted administration of high-dose chemotherapeutic agents to specific organs or regions of the body.
News I have found that this company has had two reverse splits; Dec 24, 2019 1:700 Stock Split, Oct 22, 2019 1:100 Stock Split. Reverse stock splits boost a company's share price. A higher share price is usually good, but the increase that comes from a reverse split is mostly an accounting trick. ... Whatever value it has is just distributed over fewer shares of stock, thus increasing the price. Anytime a company does a reverse split, it is a signal that a company is in distress.
My Thoughts For You The Acronym of this company brings to mind what it could mean to those who invested. "Death Comes To Hodlers" I have read many comments about this company and they are not good. Check out the comments here.
This stock could bounce up as a fake out but history does repeat itself and so the story goes, I was and was no more.